Terns Pharmaceuticals (NASDAQ:TERN) Price Target Raised to $7.50
Terns Pharmaceuticals (NASDAQ:TERN – Get Free Report) had its price objective increased by stock analysts at HC Wainwright from $5.50 to $7.50 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. HC Wainwright’s price target points to a potential upside of 9.17% from the stock’s […]
More Stories
Gilead Sciences’ (GILD) “Sector Perform” Rating Reaffirmed at Royal Bank of Canada
Gilead Sciences (NASDAQ:GILD – Get Free Report)‘s stock had its “sector perform” rating reissued by equities researchers at Royal Bank...
IQVIA’s (IQV) Outperform Rating Reaffirmed at Royal Bank of Canada
IQVIA (NYSE:IQV – Get Free Report)‘s stock had its “outperform” rating reiterated by Royal Bank of Canada in a research...
TD Private Client Wealth LLC Cuts Stock Position in Vanguard Growth ETF (NYSEARCA:VUG)
TD Private Client Wealth LLC trimmed its position in shares of Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 1.7%...
Stifel Nicolaus Issues Positive Forecast for Latham Group (NASDAQ:SWIM) Stock Price
Latham Group (NASDAQ:SWIM – Get Free Report) had its price objective boosted by stock analysts at Stifel Nicolaus from $7.70...
Unigestion Holding SA Raises Stake in PepsiCo, Inc. (NASDAQ:PEP)
Unigestion Holding SA raised its holdings in shares of PepsiCo, Inc. (NASDAQ:PEP – Free Report) by 39.0% during the third...
Albertsons Companies Target of Unusually Large Options Trading (NYSE:ACI)
Albertsons Companies, Inc. (NYSE:ACI – Get Free Report) was the target of some unusual options trading on Wednesday. Investors bought...